In the osteoarticular field, BPC-157 has shown promising results in fracture consolidation and cartilage protection
These effects, when present, are typically manageable and resolve with continued use or dose adjustment
Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide [PMID: 30191288] Laboratory literature summary: Engineering recombinant Lactococcus lactis as a delivery vehicle for BPC-157 peptide with antioxidant activities
Wang J, Wang H, Li Z, Wu Q, Lathia JD, McLendon RE, et al
An earlier 12-week trial in 300 obese adults produced a genuine positive signal the 1 mg daily dosing arm showed a statistically significant 2.8 kg mean weight loss versus 0.8 kg in the placebo group and that result is what justified moving into the larger Phase IIb trial